Table Of ContentPublikationen der
Medizinischen Klinik und Poliklinik
für Allgemeine Innere Medizin
unter der Leitung von
Prof. Dr. Tilman Sauerbruch
1992 bis 2012
Zusammenstellung, Redaktion und Gestaltung:
Ursula Moser, Medizinische Klinik und Poliklinik
2
Übersicht
Jahr Seitenzahl
1992 4 ‐ 9
1993 10 ‐ 17
1994 18 ‐ 24
1995 25 ‐ 29
1996 30 ‐ 35
1997 36 ‐ 46
1998 47 ‐ 53
1999 54 ‐ 63
2000 64 ‐ 74
2001 75 ‐ 82
2002 83 ‐ 92
2003 93 ‐ 102
2004 103 ‐ 116
2005 117 ‐ 132
2006 133 ‐ 148
2007 149 ‐ 161
2008 162 ‐ 172
2009 173 ‐ 181
2010 182 – 191
2011 192 – 206
2012 207 – 208
3
1992
1: Bayerdörffer E, Lehn N, Hatz R, Mannes GA, Oertel H, Sauerbruch T, Stolte M.
Difference in expression of Helicobacter pylori gastritis in antrum and body.
Gastroenterology. 1992 May;102(5):1575‐82.
2: Beuers U, Spengler U, Kruis W, Aydemir U, Wiebecke B, Heldwein W, Weinzierl M, Pape
GR, Sauerbruch T, Paumgartner G.
Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo‐controlled
trial.
Hepatology. 1992 Sep;16(3):707‐14.
3: Beuers U, Spengler U, Sackmann M, Paumgartner G, Sauerbruch T.
Deterioration of cholestasis after endoscopic retrograde cholangiography in advanced pri‐
mary sclerosing cholangitis.
J Hepatol. 1992 May;15(1‐2):140‐3.
4: Beuers U, Spengler U, Zwiebel FM, Pauletzki J, Fischer S, Paumgartner G.
Effect of ursodeoxycholic acid on the kinetics of the major hydrophobic bile acids in health
and in chronic cholestatic liver disease.
Hepatology. 1992 Apr;15(4):603‐8.
5: de Franchis R, Pascal JP, Ancona E, Burroughs AK, Henderson M, Fleig W, Groszmann R,
Bosch J, Sauerbruch T, Soederlund C, et al.
Definitions, methodology and therapeutic strategies in portal hypertension. A Consensus De‐
velopment Workshop, Baveno, Lake Maggiore, Italy, April 5 and 6, 1990.
J Hepatol. 1992 May;15(1‐2):256‐61.
6: Dengler TJ, Robertz‐Vaupel GM, Dengler HJ.
Albumin binding in uraemia: quantitative assessment of inhibition by endogenous ligands and
carbamylation of albumin.
Eur J Clin Pharmacol. 1992;43(5):491‐9.
7: Ewig S, Steudel A, Vogel J, Niese D.
[Pulmonary Kaposi sarcoma in patients with AIDS].
Pneumologie. 1992 Feb;46(2):52‐7.
4
8: Franke F, Sackmann M, Holl J, Pauletzki J, Neubrand M, Paumgartner G, Sauerbruch T.
Does computed tomography improve patients selection for extracorporeal shock wave lith‐
otripsy (ESWL) of radiolucent gallbladder stones?
Z Gastroenterol. 1992 Mar;30(3):180‐2.
9: Fürst H, Storck M, Jauch KW, Scheurlen C, Kaltenecker A, Wiebecke B.
[Crohn disease in advanced age].
Chirurg. 1992 Jan;63(1):26‐30.
10: Haller M, Schönfelder R, Briegel J, Pratschke E, Spengler U, Pfeiffer M, Forst H, Finsterer
U.
Renal function in the postoperative period after orthotopic liver transplantation.
Transplant Proc. 1992 Dec;24(6):2704‐6.
11: Hasan I, Wickenhöfer R, Görich J, Hartlapp JH, Reiser M.
[The palliative treatment of primary hepatocellular carcinoma by chemoembolization].
Dtsch Med Wochenschr. 1992 Apr 10;117(15):576‐80.
12: Kleber G, Sauerbruch T.
Pathophysiology and Management of Esophageal‐Varices.
Current Opinion in Gastroenterology. 1992, 8(4):583‐90.
13: Kleber G, Ansari H, Sauerbruch T.
Prophylaxis of first variceal bleeding.
Baillieres Clin Gastroenterol. 1992 Sep;6(3):563‐80.
14: Musch E, Malek M, Peter‐Katalinic J, Egge H, Rink H, Lathan B, Riedel, E
Cellular kinetics of Prenimustine versus Chlorambucil Prednisolone in vitro.
Cancer Chemotherapy Pharmacology. 1992 29 (4):297‐304
15: Paar WD, Frankus P, Dengler HJ.
The metabolism of tramadol by human liver microsomes.
Clin Investig. 1992 Aug;70(8):708‐10.
16: Paar WD, von Bergmann, K.
Pharmakokinetik und Toxikologie von Wismut.
Verdauungskrankheiten. 1992, 10:140‐3.
17: Raedsch R, Sauerbruch T.
[Use of ERCP in suspected bile duct and pancreatic cancer].
Z Gastroenterol. 1992 Oct;30(10):765‐9.
18: Robertz‐Vaupel GM, Glasmacher AG, Brilla H, Dengler HJ
5
Laborchemische Parameter bei Patienten mit Lebermetastasen.
Verdauungskrankheiten. 1992, 10: 197‐201.
19: Robertz‐Vaupel GM, Lindecken KD, Edeki T, Funke C, Belwon S, Dengler HJ.
Disposition of antipyrine in patients with extensive metastatic liver disease.
Eur J Clin Pharmacol. 1992;42(5):465‐9.
20: Rockstroh JK, Schmieder RE, Schächinger H, Messerli FH.
Stress response pattern in obesity and systemic hypertension.
Am J Cardiol. 1992 Oct 15;70(11):1035‐9.
21: Rockstroh JK, Schmieder RE.
Diagnostik der linksventrikulären Hypertrophie.
Münchener Medizinische Wochenschrift. 1992;134(13):220‐22.
22: Rockstroh JK, Schmieder RE.
Durch LVH beeinträchtigte systolische und diastolische Funktion.
Münchener Medizinische Wochenschrift. 1992;134(13):234‐236.
23: Sackmann M, Pauletzki J, Delius M, Holl J, Neubrand M, Sauerbruch T, Paumgartner G.
Noninvasive therapy of gallbladder calculi with a radiopaque rim.
Gastroenterology. 1992 Mar;102(3):988‐93.
24: Sauerbruch T, Holl J, Sackmann M, Paumgartner G.
Extracorporeal lithotripsy of pancreatic stones in patients with chronic pancreatitis and pain:
a prospective follow up study.
Gut. 1992 Jul;33(7):969‐72.
25: Sauerbruch T, Holl J, Sackmann M, Paumgartner G.
Fragmentation of bile duct stones by extracorporeal shock‐wave lithotripsy: a five‐year ex‐
perience.
Hepatology. 1992 Feb;15(2):208‐14.
26: Sauerbruch T, Kleber G.
Upper gastrointestinal endoscopy in patients with portal hypertension.
Endoscopy. 1992 Jan‐Feb;24(1‐2):45‐51.
27: Sauerbruch T.
Non‐surgical management of bile duct stones refractory to routine endoscopic measures.
Baillieres Clin Gastroenterol. 1992 Nov;6(4):799‐817.
28: Sauerbruch T.
Endoscopic management of bile duct stones.
6
J Gastroenterol Hepatol. 1992 May‐Jun;7(3):328‐34.
29: Sauerbruch T.
[Portal hypertension: beta‐receptor blockers for the prevention of upper intestinal leeding].
Dtsch Med Wochenschr. 1992 Mar 27;117(13):520‐1.
30: Sauerbruch T.
[Therapy of pancreatic duct calculi: cosmetic or causal therapy?].
Bildgebung. 1992 Mar;59 Suppl 1:18‐9.
31: Sauerbruch T.
Nichtoperative Behandlung von Gallenblasensteinen.
Chir Gastroenterol 1992;8 (Suppl. 3):27‐29.
32: Sauerbruch T, Neubrand M.
Nonsurgical management of gallstones.
Prog Liver Dis. 1992;10:193‐218.
33: Sauter G, Ruckdeschel G, Sauerbruch T.
Antibiotic prevention and therapy of infectious complications in ERCP].
Leber Magen Darm. 1992 Sep;22(5):173‐6.
34: Sauter G, Ruckdeschel G, Sauerbruch T.
Antibiotische Prophylaxe und Therapie infektiöser Komplikationen.
Z Gastroenterol. 1992; 30(9):705‐08.
35: Scheurlen C, Neubrand M, Fischer G, Soehnchen R, Kröner G, Sauerbruch T.
[Muscle pain, scleroderma‐like skin changes and eosinophilia following administration of a
psychotropic drug].
Internist (Berl). 1992 Apr;33(4):269‐73.
36: Scheurlen C, Kruis W.
5‐Aminosalicyclic acid preparation in the therapy of chronic inflammatory bowel diseases.
Innere Medizin. 1992; 19 (3):88‐93.
37. Scheurlen C.
Diät und Ω‐3‐Fettsäuren bei chronisch entzündlichen Darmerkrankungen.
Heilkunst. 1992; 105: 124‐130.
38. Scheurlen C.
Natürlicher Verlauf und Komplikationen beim Morbus Crohn.
Bauchredner. 1992; 30: 9‐16
7
39: Scheurlen C, Wedel S, Kruis W, Zwiebel FM, Allgayer H, Scholz R.
Olsalazine‐related diarrhoea: does rat intestine adapt in vivo?
Scand J Gastroenterol. 1992 Apr;27(4):311‐6.
40: Schmidt EK, von Unruh GE, Paar WD, Dengler HJ.
A gas chromatographic/mass spectrometric assay for prenylamine suitable for pharmacoki‐
netic studies of the racemate and the enantiomers.
Biol Mass Spectrom. 1992 Feb;21(2):103‐8.
41: Schmieder RE, Rüddel H, Schlebusch H, Rockstroh J, Schächinger H, Schulte W.
Impact of antihypertensive therapy with isradipine and metoprolol on early markers of hyper‐
tensive nephropathy.
Am J Hypertens. 1992 May;5(5 Pt 1):318‐21.
42: Spengler U, Möller A, Jung MC, Messer G, Zachoval R, Hoffmann RM, Eisenburg
J, Paumgartner G, Riethmüller G, Weiss EH, et al.
T lymphocytes from patients with primary biliary cirrhosis produce reduced amounts of lym‐
photoxin, tumor necrosis factor and interferon‐gamma upon mitogen stimulation.
J Hepatol. 1992 May;15(1‐2):129‐35.
43: Stiehl A, Sauerbruch T.
Guidelines for endoscopic studies of infectious cholangitis].
Z Gastroenterol. 1992 Mar;30(3):241‐2.
44: Stiehl A, Sauerbruch T.
[Guidelines for endoscopic studies in primary sclerosing cholangitis].
Z Gastroenterol. 1992 Apr;30(4):313‐4.
45: Zwiebel FM, Sauerbruch T.
Quality assurance by computerized endoscopy record systems.
Endoscopy. 1992 Jul;24 Suppl 2:527‐31.
8
1993
1: Bode G, Mauch F, Ditschuneit H, Malfertheiner P.
Identification of structures containing polyphosphate in Helicobacter pylori.
J Gen Microbiol. 1993 Dec;139(12):3029‐33.
2: Bode G, Mauch F, Malfertheiner P.
The coccoid forms of Helicobacter pylori. Criteria for their viability.
Epidemiol Infect. 1993 Dec;111(3):483‐90.
3: Böhler J, Becker A, Reetze‐Bonorden P, Woitas R, Keller E, Schollmeyer P.
Effect of antihypertensive drugs on glomerular hyperfiltration and renal haemodynamics.
Comparison of captopril with nifedipine, metoprolol and celiprolol.
Eur J Clin Pharmacol. 1993;44 Suppl 1:S57‐61.
4: Brensing KA, Smyczek B, Waibel‐Treber S, Wildt L, Leyendecker G.
Luteinizing hormone (LH) pulsatility during the oestradiol‐ and oestradiol/progesterone‐
induced LH surge in the human female.
Hum Reprod. 1993 Nov;8 Suppl 2:72‐6.
5: Büchler M, Malfertheiner P, Uhl W, Schölmerich J, Stöckmann F, Adler G, Gaus W, Rolle K,
Beger HG.
Gabexate mesilate in human acute pancreatitis. German Pancreatitis Study Group.
Gastroenterology. 1993 Apr;104(4):1165‐70.
6: Domínguez‐Muñoz JE, Malfertheiner P.
[Diagnosis and staging of chronic pancreatitis (I). The role of imaging methods].
Rev Esp Enferm Dig. 1993 May;83(5):367‐72.
7: Domínguez‐Muñoz JE, Malfertheiner P.
[Diagnosis and staging of chronicpancreatitis (II). The role of functional tests].
Rev Esp Enferm Dig. 1993 Jun;83(6):453‐7.
8: Domínguez‐Muñoz JE, Malfertheiner P.
Management of severe acute pancreatitis.
Gastroenterologist. 1993 Dec;1(4):248‐56.
9
9: Domínguez‐Muñoz JE, Pieramico O, Büchler M, Malfertheiner P.
Clinical utility of the serum pancreolauryl test in diagnosis and staging of chronic pancreatitis.
Am J Gastroenterol. 1993 Aug;88(8):1237‐41.
10: Domínguez‐Muñoz JE, Pieramico O, Büchler M, Malfertheiner P.
Ratios of different serum pancreatic enzymes in the diagnosis and staging of chronic pan‐
creatitis.
Digestion. 1993;54(4):231‐6.
11: Domínguez‐Muñoz JE, Manes G, Büchler M, Malfertheiner P.
Assessment of the fibrogenetic activity in chronic pancreatitis. The role of circulating levels of
extracellular matrix components.
Int J Pancreatol. 1993 Dec;14(3):253‐9.
12: Dumoulin FL, Daniel WG, Lichtlen P, Schmidt RE.
[Pulmonary thromboembolism in antiphospholipid syndrome].
Dtsch Med Wochenschr. 1993 Jun 18;118(24):903‐6.
13: Ewig S, Rockstroh JK, Christ F.
Pneumocystis carinii pneumonia presenting as an upper lobe cavity after aerosolized pen‐
tamidine prophylaxis in an HIV‐infected patient.
Scand J Infect Dis. 1993;25(3):379‐83.
14: Ewig S, Rockstroh JK, Seitz HM, Marklein G, Christ F, Lüchters G, Brackmann HH, Lüderitz
B.
Pneumocystis carinii infections in HIV‐infected hemophiliacs during aerosolized pentamidine
prophylaxis.
Respiration. 1993;60(3):186‐92.
15: Ewig S, Schaal KP, Steudel A, Nikorowitsch R, von Kempis J, Staib P, Vaupel HA.
[42‐year‐old patient with fever and a palpable abdominal tumor].
Internist. (Berl). 1993 Jan;34(1):59‐62. German.
16: Fischer S, Neubrand M, Paumgartner G.
Biotransformation of orally administered ursodeoxycholic acid in man as observed in gall‐
bladder bile, serum and urine.
Eur J Clin Invest. 1993 Jan;23(1):28‐36.
10
Description:Hepatology. 1992 Feb;15(2):208-14. 26: Sauerbruch T, Kleber G. Upper gastrointestinal endoscopy in patients with portal hypertension. Endoscopy. 1992 Jan-Feb;24(1-2):45-51. 1994 Jan 7;119(1-2):27-30. 9: Friedrich JM, Leibing U, Pfeifer T, Schnarkowski P, Büchler M, Malfertheiner P, Beger HG.